BG105218A - The use of optically pure (+) norcisapride for treating gastro-esophageal reflux disease - Google Patents
The use of optically pure (+) norcisapride for treating gastro-esophageal reflux diseaseInfo
- Publication number
- BG105218A BG105218A BG105218A BG10521801A BG105218A BG 105218 A BG105218 A BG 105218A BG 105218 A BG105218 A BG 105218A BG 10521801 A BG10521801 A BG 10521801A BG 105218 A BG105218 A BG 105218A
- Authority
- BG
- Bulgaria
- Prior art keywords
- norcisapride
- compound
- optically pure
- reflux disease
- esophageal reflux
- Prior art date
Links
- ZDLILMQNLSEPLK-UHFFFAOYSA-N 2-chloro-5-methoxy-n-piperidin-4-ylpyrimidin-4-amine Chemical compound COC1=CN=C(Cl)N=C1NC1CCNCC1 ZDLILMQNLSEPLK-UHFFFAOYSA-N 0.000 title abstract 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000002411 adverse Effects 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- OMLDMGPCWMBPAN-YPMHNXCESA-N norcisapride Chemical compound CO[C@H]1CNCC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC OMLDMGPCWMBPAN-YPMHNXCESA-N 0.000 abstract 2
- 230000003389 potentiating effect Effects 0.000 abstract 2
- 206010013710 Drug interaction Diseases 0.000 abstract 1
- 206010052105 Gastrointestinal hypomotility Diseases 0.000 abstract 1
- 206010021518 Impaired gastric emptying Diseases 0.000 abstract 1
- 201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 abstract 1
- 239000002111 antiemetic agent Substances 0.000 abstract 1
- 229940125683 antiemetic agent Drugs 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 230000005176 gastrointestinal motility Effects 0.000 abstract 1
- 208000001288 gastroparesis Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/123,892 US6147093A (en) | 1996-07-19 | 1998-07-28 | Methods for treating gastroesophageal reflux disease |
| PCT/US1999/016736 WO2000006165A1 (en) | 1998-07-28 | 1999-07-23 | Methods and compositions for treating gastro-esophageal reflux disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG105218A true BG105218A (en) | 2001-11-30 |
Family
ID=22411520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105218A BG105218A (en) | 1998-07-28 | 2001-02-05 | The use of optically pure (+) norcisapride for treating gastro-esophageal reflux disease |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US6147093A (cs) |
| EP (1) | EP1100502A1 (cs) |
| JP (1) | JP2002521448A (cs) |
| KR (1) | KR20010071047A (cs) |
| CN (1) | CN1320036A (cs) |
| AR (1) | AR019947A1 (cs) |
| AU (1) | AU5126099A (cs) |
| BG (1) | BG105218A (cs) |
| BR (1) | BR9912581A (cs) |
| CA (1) | CA2338465A1 (cs) |
| CO (1) | CO5060499A1 (cs) |
| CZ (1) | CZ295776B6 (cs) |
| EA (1) | EA200100188A1 (cs) |
| EE (1) | EE200100051A (cs) |
| HK (1) | HK1041226A1 (cs) |
| HR (1) | HRP20010075A2 (cs) |
| HU (1) | HUP0102979A3 (cs) |
| ID (1) | ID28894A (cs) |
| IL (1) | IL141047A0 (cs) |
| NO (1) | NO20010464L (cs) |
| NZ (1) | NZ509671A (cs) |
| PL (1) | PL345764A1 (cs) |
| SK (1) | SK1202001A3 (cs) |
| TR (1) | TR200100921T2 (cs) |
| WO (1) | WO2000006165A1 (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6147093A (en) * | 1996-07-19 | 2000-11-14 | Sepracor Inc. | Methods for treating gastroesophageal reflux disease |
| EP1000029B1 (en) * | 1997-07-11 | 2003-10-01 | Janssen Pharmaceutica N.V. | (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| DE10314916A1 (de) | 2003-04-01 | 2004-10-21 | Endress + Hauser Flowtec Ag, Reinach | Vorrichtung zur Bestimmung und/oder Überwachung des Volumen- und/oder Massenstroms eines Mediums |
| CA2551171C (en) * | 2003-12-23 | 2012-07-10 | Bio-Medisinsk Innovasjon As | Modulators of peripheral 5-ht receptors |
| US8138204B2 (en) * | 2004-01-07 | 2012-03-20 | Aryx Therapeutics, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| PT1704146E (pt) | 2004-01-07 | 2010-06-30 | Aryx Therapeutics Inc | Compostos estereoisoméricos e processos para o tratamento de distúrbios gastrointestinais e do sistema nervoso central |
| US8524736B2 (en) | 2004-01-07 | 2013-09-03 | Armetheon, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| US20050160544A1 (en) * | 2004-01-26 | 2005-07-28 | Marc Geller | Contoured grill brush |
| JP5308818B2 (ja) * | 2005-08-31 | 2013-10-09 | アルメテオン、インコーポレイテッド | 胃腸系および中枢神経系障害の治療に有用な立体異性化合物の合成方法および中間体 |
| WO2007149929A1 (en) * | 2006-06-23 | 2007-12-27 | Aryx Therapeutics, Inc. | Piperidine derivatives for the treatment of gastrointestinal and cns disorders |
| US10570127B1 (en) | 2018-11-05 | 2020-02-25 | Renexxion, Llc | Material and methods for the treatment of gastro-intestinal disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4962115A (en) * | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| US5057525A (en) * | 1981-10-01 | 1991-10-15 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives |
| US5137896A (en) * | 1981-10-01 | 1992-08-11 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| EP1170010A3 (en) * | 1992-07-07 | 2004-05-19 | Sepracor Inc. | Method of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| EP1145715A3 (en) * | 1992-07-07 | 2004-05-19 | Sepracor Inc. | Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
| AU7397194A (en) * | 1993-07-06 | 1995-02-06 | Mcneil-Ppc, Inc. | H2 antagonist-gastrointestinal motility agent combinations |
| US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
| US6147093A (en) * | 1996-07-19 | 2000-11-14 | Sepracor Inc. | Methods for treating gastroesophageal reflux disease |
| US5739151A (en) * | 1996-07-19 | 1998-04-14 | Sepracor Inc. | Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| EP1000029B1 (en) * | 1997-07-11 | 2003-10-01 | Janssen Pharmaceutica N.V. | (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
-
1998
- 1998-07-28 US US09/123,892 patent/US6147093A/en not_active Expired - Fee Related
-
1999
- 1999-07-23 WO PCT/US1999/016736 patent/WO2000006165A1/en not_active Ceased
- 1999-07-23 KR KR1020017001188A patent/KR20010071047A/ko not_active Ceased
- 1999-07-23 BR BR9912581-1A patent/BR9912581A/pt not_active Application Discontinuation
- 1999-07-23 NZ NZ509671A patent/NZ509671A/en unknown
- 1999-07-23 PL PL99345764A patent/PL345764A1/xx not_active Application Discontinuation
- 1999-07-23 HK HK02103109.0A patent/HK1041226A1/zh unknown
- 1999-07-23 AU AU51260/99A patent/AU5126099A/en not_active Abandoned
- 1999-07-23 EE EEP200100051A patent/EE200100051A/xx unknown
- 1999-07-23 SK SK120-2001A patent/SK1202001A3/sk unknown
- 1999-07-23 HR HR20010075A patent/HRP20010075A2/hr not_active Application Discontinuation
- 1999-07-23 JP JP2000562019A patent/JP2002521448A/ja active Pending
- 1999-07-23 EP EP99935877A patent/EP1100502A1/en not_active Withdrawn
- 1999-07-23 IL IL14104799A patent/IL141047A0/xx unknown
- 1999-07-23 ID IDW20010484A patent/ID28894A/id unknown
- 1999-07-23 CA CA002338465A patent/CA2338465A1/en not_active Abandoned
- 1999-07-23 EA EA200100188A patent/EA200100188A1/ru unknown
- 1999-07-23 HU HU0102979A patent/HUP0102979A3/hu unknown
- 1999-07-23 CN CN99811374A patent/CN1320036A/zh active Pending
- 1999-07-23 CZ CZ2001348A patent/CZ295776B6/cs not_active IP Right Cessation
- 1999-07-23 TR TR2001/00921T patent/TR200100921T2/xx unknown
- 1999-07-28 CO CO99047624A patent/CO5060499A1/es unknown
- 1999-07-28 AR ARP990103729A patent/AR019947A1/es not_active Application Discontinuation
-
2000
- 2000-05-18 US US09/573,423 patent/US6242465B1/en not_active Expired - Fee Related
-
2001
- 2001-01-26 NO NO20010464A patent/NO20010464L/no not_active Application Discontinuation
- 2001-02-05 BG BG105218A patent/BG105218A/xx unknown
- 2001-03-16 US US09/809,165 patent/US6632827B2/en not_active Expired - Fee Related
-
2003
- 2003-09-03 US US10/653,072 patent/US20040044039A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010071047A (ko) | 2001-07-28 |
| US20010020031A1 (en) | 2001-09-06 |
| ID28894A (id) | 2001-07-12 |
| CN1320036A (zh) | 2001-10-31 |
| SK1202001A3 (en) | 2001-08-06 |
| HRP20010075A2 (en) | 2002-02-28 |
| AR019947A1 (es) | 2002-03-27 |
| CO5060499A1 (es) | 2001-07-30 |
| EA200100188A1 (ru) | 2001-08-27 |
| US6632827B2 (en) | 2003-10-14 |
| PL345764A1 (en) | 2002-01-02 |
| BR9912581A (pt) | 2001-05-02 |
| JP2002521448A (ja) | 2002-07-16 |
| CZ295776B6 (cs) | 2005-11-16 |
| NO20010464D0 (no) | 2001-01-26 |
| NZ509671A (en) | 2003-08-29 |
| CZ2001348A3 (cs) | 2002-01-16 |
| HUP0102979A3 (en) | 2002-01-28 |
| US6242465B1 (en) | 2001-06-05 |
| HUP0102979A2 (hu) | 2001-12-28 |
| EE200100051A (et) | 2002-06-17 |
| HK1041226A1 (zh) | 2002-07-05 |
| EP1100502A1 (en) | 2001-05-23 |
| AU5126099A (en) | 2000-02-21 |
| CA2338465A1 (en) | 2000-02-10 |
| WO2000006165A1 (en) | 2000-02-10 |
| US6147093A (en) | 2000-11-14 |
| IL141047A0 (en) | 2002-02-10 |
| US20040044039A1 (en) | 2004-03-04 |
| NO20010464L (no) | 2001-03-23 |
| TR200100921T2 (tr) | 2001-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2245768A1 (en) | Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride | |
| BG105218A (en) | The use of optically pure (+) norcisapride for treating gastro-esophageal reflux disease | |
| PT1259489E (pt) | Compostos azapoliciclicos condensados con arilo. | |
| AU6926800A (en) | Bupropion metabolites and methods of their synthesis and use | |
| DE60140693D1 (en) | Ankheiten | |
| CA2272584A1 (en) | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
| MY111616A (en) | Nover (r)-5-carbamoyl-8-fluoro-3-n, n-disubstituted-amino-3, 4-dihydro-2h-1-benzopyrans | |
| UA87653C2 (en) | 1,2,4-oxadiazols as modulators of receptor-5 for metabotropic glutamate | |
| MXPA04000625A (es) | Piperidinas sustituidas como moduladores del receptor de melanocortina. | |
| EG20218A (en) | Process for preparing of substituted 3 aminoquinuclidines | |
| EP1165086A4 (en) | BUPROPION METABOLITES AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
| WO2003020212A3 (en) | Treatment for central nervous system disorders | |
| HK1049333A1 (zh) | 以环状琥珀酸酯代替内酰胺，作为制造Aβ蛋白质的抑制剂 | |
| GEP20043366B (en) | Benzothiophene Derivative Compounds Process of Preparation and Use Thereof | |
| MY140835A (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| DE69739970D1 (de) | Methode zur behandlung sexueller fehlfunktionen | |
| MXPA04004368A (es) | Metodos para tratar depresion y otros transtornos del sistema nervioso central utilizando desmetil-y didesmetil-metabolitos del citalopram enantiomericamente enriquecidos. | |
| BG103949A (en) | A new salt | |
| FR2724933B1 (cs) | ||
| BG101929A (en) | Benzamides for neurodegenerative disorder treatment | |
| CA2123704A1 (en) | Methods and compositions utilizing pure s(+)isomer fluoxetine | |
| GB0019008D0 (en) | Therapeutic compounds | |
| EP0703232A3 (en) | 2,3-dihydro-1H-isoindole derivatives, process for their preparation and their use as serotonin re-assimilation inhibitors | |
| IL154915A0 (en) | Method for producing chiral compounds | |
| EP0769496A4 (en) | 2,3-DIHYDROBENZOFURAN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF |